Association between Tocilizumab treatment of hyper-inflammatory patients with COVID-19 in a critical care setting and an elevated incidence of hospital acquired bacterial and invasive fungal infections. Breadcrumbs UL Home Research Publications Year of Publication 2022 Journal Journal Of Hospital Infection DOI 10.1016/j.jhin.2022.04.007